AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32958573 — intervention group
Group type: COMPARATOR
Intervention: Peanut- or tree-nut-induced anaphylaxis during Christmas, Diwali, Chinese New Year, or Eid al-Adha
Number of subjects: 1390
Study 33779943 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide
Number of subjects: 305
Study 33779943 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 305
Study 34709720 — intervention group
Group type: EXPERIMENTAL
Intervention: Written Clinical Reasoning Prompt (WCRP)
Number of subjects: 24
Study 34709720 — intervention group
Group type: COMPARATOR
Intervention: Control group (without using the WCRP)
Number of subjects: 24
Study 33210752 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic non-electrolyte fluid (glycine 1.5%)
Number of subjects: 23
Study 33210752 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic electrolyte fluid (Ringer's acetate or 0.9% saline)
Number of subjects: 23
Study 33210752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of fluid
Number of subjects: 23
Study 33210752 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-electrolyte fluid
Number of subjects: 23
Study 33210752 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 23
Study 35012478 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous (weekly) use of a clinical decision support system (CDSS) for medication optimization.
Number of subjects: 0
Study 35012478 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 0
Study 32574011 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614
Study 32574011 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 1614
Study 32574011 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion and Vehicle
Number of subjects: 1614
Study 35179810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 61
Study 35179810 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (0.25 mg/kg)
Number of subjects: 61
Study 34411292 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 64
Study 34411292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34411292 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (CACE for adherence >90%)
Number of subjects: 64
Study 32688208 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 110
Study 32688208 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM) protocol
Number of subjects: 110
Study 36478588 — intervention group
Group type: EXPERIMENTAL
Intervention: Steamed hay
Number of subjects: 43
Study 36478588 — intervention group
Group type: EXPERIMENTAL
Intervention: Haylage
Number of subjects: 43
Study 33833225 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (0.17 mg/kg)
Number of subjects: 0
Study 33833225 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 32349977 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA-guided fluid management (BIA and traditional clinical methods)
Number of subjects: 240
Study 32349977 — intervention group
Group type: COMPARATOR
Intervention: Control (only traditional clinical methods)
Number of subjects: 240
Study 36237885 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 132
Study 36237885 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral nerve block (TPVB)
Number of subjects: 132
Study 36237885 — intervention group
Group type: COMPARATOR
Intervention: Control group (general anesthesia)
Number of subjects: 132
Study 34011470 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop (90-minute session of injury prevention strategies)
Number of subjects: 57
Study 34011470 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study 32809003 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1500 mg), hydrocortisone (50 mg), thiamine (100 mg) every 6 hours for 4 days (n=103)
Number of subjects: 205
Study 32809003 — intervention group
Group type: COMPARATOR
Intervention: Placebo in matching volumes (n=102)
Number of subjects: 205
Study 32809003 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid, corticosteroids, and thiamine
Number of subjects: 205
Study 32809003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 34382875 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg intravenously every 24 weeks
Number of subjects: 608
Study 33587505 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg VRC01
Number of subjects: 2701
Study 33587505 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg VRC01
Number of subjects: 2701
Study 33587505 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 2701
Study 32142491 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 30 min
Number of subjects: 44
Study 32142491 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 40 min
Number of subjects: 44
Study 32142491 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 50 min
Number of subjects: 44
Study 32142491 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 60 min
Number of subjects: 44
Study 33933597 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid spread of ictal fast activity (IFA)
Number of subjects: 45
Study 32080941 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional enrichment of current forest patches
Number of subjects: 3
Study 32080941 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-species plantations in previously non-forested patches
Number of subjects: 3
Study 32080941 — intervention group
Group type: EXPERIMENTAL
Intervention: Planting biodiversity-enhancing species
Number of subjects: 3
Study 32080941 — intervention group
Group type: EXPERIMENTAL
Intervention: Planting pest-resistant species
Number of subjects: 3
Study 32080941 — intervention group
Group type: EXPERIMENTAL
Intervention: Planting biodiversity-enhancing species vs. drought-tolerant species
Number of subjects: 3
Study 36316074 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigate intervention (nurse navigation, systematic monitoring of patient-reported outcomes, physical exercise)
Number of subjects: 518
Study 36316074 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 518
Study 32081401 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray wolf optimization (GWO) algorithm for optimal sizing of energy storage systems in micro-grids
Number of subjects: 0
Study 32081401 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage randomization design (TSRD) for modeling wind power uncertainty
Number of subjects: 0
Study 32673065 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling with men (4 sessions)
Number of subjects: 102
Study 32673065 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 102
Study 34481342 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 117
Study 34481342 — intervention group
Group type: COMPARATOR
Intervention: Sham tape application (placebo group)
Number of subjects: 117
Study 34481342 — intervention group
Group type: COMPARATOR
Intervention: No application (control group)
Number of subjects: 117
Study 35192105 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% tanfanercept, twice daily for eight weeks
Number of subjects: 100
Study 34634064 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly regret lottery with activity trackers and daily text message reminders
Number of subjects: 40
Study 34634064 — intervention group
Group type: COMPARATOR
Intervention: Activity trackers and daily text message reminders (control arm)
Number of subjects: 40
Study 32271051 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress induction
Number of subjects: 238
Study 32271051 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 238
Study 32271051 — intervention group
Group type: EXPERIMENTAL
Intervention: Math anxiety
Number of subjects: 238
Study 32271051 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline perceived stress
Number of subjects: 238
Study 33964194 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Dorema ammoniacum cream
Number of subjects: 49
Study 33770629 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient balloon catheter (n = 205)
Number of subjects: 448
Study 33770629 — intervention group
Group type: COMPARATOR
Intervention: Inpatient prostaglandin (n = 243)
Number of subjects: 448
Study 36280536 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication (Open Group)
Number of subjects: 108
Study 36280536 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication (Hidden Group)
Number of subjects: 108
Study 36280536 — intervention group
Group type: COMPARATOR
Intervention: Study-supervised taper and discontinuation of ineffective antidepressant medication
Number of subjects: 108
Study 35429191 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based karate intervention
Number of subjects: 388
Study 33471361 — intervention group
Group type: COMPARATOR
Intervention: Traditional antibiotic therapy (from days 3 to 10 of the menstrual cycle)
Number of subjects: 70
Study 33471361 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics and molded sorbent-modified polyvinylpyrrolidone (FSMP) inserted from days 5 to 10
Number of subjects: 70
Study 33471361 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics and FSMP
Number of subjects: 70
Study 32740576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection
Number of subjects: 80
Study 32740576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (≥1 ml per time)
Number of subjects: 80
Study 32740576 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hyaluronic acid injection)
Number of subjects: 80
Study 36251313 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened for atrial fibrillation
Number of subjects: 0
Study 36251313 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33369879 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 66
Study 33369879 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT + EAA
Number of subjects: 66
Study 33369879 — intervention group
Group type: EXPERIMENTAL
Intervention: EAA
Number of subjects: 66
Study 32143630 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS)
Number of subjects: 166
Study 32143630 — intervention group
Group type: COMPARATOR
Intervention: Conventional tools (free internet access, pharmaceutical pocket guide, pocket guide antibiotic therapy)
Number of subjects: 166
Study 36045358 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA)
Number of subjects: 134
Study 36045358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue (FG)
Number of subjects: 134
Study 36045358 — intervention group
Group type: COMPARATOR
Intervention: Usual haemostasis
Number of subjects: 134
Study 34740927 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE intervention (collaborative care mental health intervention)
Number of subjects: 15
Study 35958808 — intervention group
Group type: EXPERIMENTAL
Intervention: Early comprehensive intervention of skin contact combined with breastfeeding
Number of subjects: 300
Study 35958808 — intervention group
Group type: COMPARATOR
Intervention: Control group (postnatal naked contact, physical examination after late navel severing, routine nursing intervention)
Number of subjects: 300
Study 33599552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (n = 16)
Number of subjects: 36
Study 33599552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (n = 20)
Number of subjects: 36
Study 33599552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal anti-VEGF injections (ranibizumab or aflibercept)
Number of subjects: 36
Study 32481420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% NaOCl + Carisolv III
Number of subjects: 40
Study 32481420 — intervention group
Group type: COMPARATOR
Intervention: 2% NaOCl
Number of subjects: 40
Study 32481420 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl
Number of subjects: 40
Study 32481420 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline (PBS)
Number of subjects: 40
Study 35749864 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 96
Study 35749864 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-fowler position
Number of subjects: 96
Study 35749864 — intervention group
Group type: COMPARATOR
Intervention: Control group (daily activities)
Number of subjects: 96
Study 32877722 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard high-calorie, high-fat meal administered via naso-gastro-intestinal tube
Number of subjects: 8
Study 34487910 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-tailored intervention
Number of subjects: 501
Study 34487910 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-tailored intervention
Number of subjects: 501
Study 34487910 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 501
Study 32073501 — intervention group
Group type: COMPARATOR
Intervention: Certified Asthma Educator (AE-C)
Number of subjects: 223
Study 32073501 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs)
Number of subjects: 223
Study 32996017 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal school-based health promotion intervention program
Number of subjects: 215
Study 32996017 — intervention group
Group type: COMPARATOR
Intervention: Attention control curriculum
Number of subjects: 215
Study 32144895 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose exercise (8 kcal/kg of body weight per week)
Number of subjects: 108
Study 32144895 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose exercise (20 kcal/kg of body weight per week)
Number of subjects: 108
Study 35901476 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of bupivacaine (0.25%)
Number of subjects: 75
Study 35901476 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of bupivacaine (0.25%) and 100 mg magnesium sulphate
Number of subjects: 75
Study 35901476 — intervention group
Group type: COMPARATOR
Intervention: Sham ESPB (2 mL normal saline)
Number of subjects: 75
Study 33949201 — intervention group
Group type: COMPARATOR
Intervention: Serum metabolomics and proteins/cytokines
Number of subjects: 135
Study 33949201 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolomic fingerprints
Number of subjects: 135
Study 33949201 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway analysis of ARDS differentiating metabolites
Number of subjects: 135
Study 33949201 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal tracking of identified pathway metabolites
Number of subjects: 135
Study 33949201 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of metabolic profiles
Number of subjects: 135
Study 32986295 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 10^7 autologous expanded mesenchymal stem cells (AdMSCs)
Number of subjects: 16
Study 32986295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 33166905 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Motor Competence (LMC) group
Number of subjects: 160
Study 33166905 — intervention group
Group type: COMPARATOR
Intervention: Typically Developing (TD) group
Number of subjects: 160
Study 33166905 — intervention group
Group type: EXPERIMENTAL
Intervention: Males with LMC
Number of subjects: 160
Study 33166905 — intervention group
Group type: EXPERIMENTAL
Intervention: Females from both competence groups
Number of subjects: 160
Study 34406172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C Solution (VCS)
Number of subjects: 3115
Study 34406172 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate Solution (STS)
Number of subjects: 3115
Study 34406172 — intervention group
Group type: COMPARATOR
Intervention: Distilled Water (DW)
Number of subjects: 3115
Study 33528911 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-OSU6162 15 mg b.i.d. for 4 weeks, then 30 mg b.i.d. for 4 weeks, then 45 mg b.i.d. for 4 weeks
Number of subjects: 33
Study 33528911 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-OSU6162
Number of subjects: 33
Study 35915011 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training in pain measurement using structured scales (e.g., Face Scale for Pain Assessment of Preterm Infants, Japanese version of the Premature Infant Pain Profile)
Number of subjects: 64
Study 35915011 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 64
Study 34678199 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional healer-delivered point-of-care HIV testing
Number of subjects: 500
Study 34678199 — intervention group
Group type: COMPARATOR
Intervention: Referral to local clinics for HIV testing
Number of subjects: 500
Study 35413901 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography urography (CTU) with corticomedullary phase (CMP)
Number of subjects: 2195
Study 35413901 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopy
Number of subjects: 2195
Study 34459161 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation group
Number of subjects: 15
Study 34459161 — intervention group
Group type: COMPARATOR
Intervention: Cathodal stimulation group
Number of subjects: 15
Study 34459161 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation group
Number of subjects: 15
Study 36002315 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 35 mg twice per day for 3 months
Number of subjects: 26
Study 36002315 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 26
Study 36002315 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 26
Study 32827553 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Mobilization (NM) plus Stabilization Exercises (SE)
Number of subjects: 60
Study 32827553 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial Release (MFR) plus Stabilization Exercises (SE)
Number of subjects: 60
Study 32827553 — intervention group
Group type: COMPARATOR
Intervention: Stabilization Exercises (SE) only
Number of subjects: 60
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR)
Number of subjects: 23889
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaussian Naive Bayes (GNB)
Number of subjects: 23889
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machines (SVM)
Number of subjects: 23889
Study 36747139 — intervention group
Group type: COMPARATOR
Intervention: Linear Regression Analysis
Number of subjects: 23889
Study 36747139 — intervention group
Group type: COMPARATOR
Intervention: LASSO
Number of subjects: 23889
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: K-fold Cross Validation (LR)
Number of subjects: 23889
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: K-fold Cross Validation (GNB)
Number of subjects: 23889
Study 36747139 — intervention group
Group type: EXPERIMENTAL
Intervention: K-fold Cross Validation (SVM)
Number of subjects: 23889
Study 33661184 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) at 2 mA for 20 minutes twice daily over 5 days
Number of subjects: 14
Study 33661184 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study 32731118 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) at individualized doses (maximum of 200 mg/day)
Number of subjects: 108
Study 32731118 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV)
Number of subjects: 108
Study 32731118 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) monotherapy
Number of subjects: 108
Study 36027567 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive oxygen target (Pao2 of 9 to 10 kPa)
Number of subjects: 789
Study 36027567 — intervention group
Group type: COMPARATOR
Intervention: Liberal oxygen target (Pao2 of 13 to 14 kPa)
Number of subjects: 789
Study 36027567 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive oxygen target
Number of subjects: 789
Study 36027567 — intervention group
Group type: COMPARATOR
Intervention: Liberal oxygen target
Number of subjects: 789
Study 33303314 — intervention group
Group type: EXPERIMENTAL
Intervention: SGB therapy with 7 mL 0.5% ropivacaine
Number of subjects: 60
Study 33303314 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SGB therapy)
Number of subjects: 60
Study 35538377 — intervention group
Group type: EXPERIMENTAL
Intervention: 100,000 IU of Vitamin D2 once weekly for twelve weeks (Group 2)
Number of subjects: 48
Study 35538377 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU of Vitamin D2 daily for ten days followed by 2,000 IU of Vitamin D3 daily for 74 days (Group 3)
Number of subjects: 48
Study 35538377 — intervention group
Group type: COMPARATOR
Intervention: 100,000 IU of Vitamin D2 (Group 1)
Number of subjects: 48
Study 34329389 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.016 × 0.022 nickel‐titanium lower reverse curve of Spee archwire (LRCA)
Number of subjects: 42
Study 34329389 — intervention group
Group type: COMPARATOR
Intervention: Metal anterior bite turbos (ABTs)
Number of subjects: 42
Study 35777880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (real-world setting)
Number of subjects: 8038
Study 35777880 — intervention group
Group type: COMPARATOR
Intervention: Control group (simulated setting)
Number of subjects: 8038
Study 35777880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 8038
Study 34019535 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) along with standard of care (SOC)
Number of subjects: 80